Binding of CDK9 to TRAF2

J Cell Biochem. 1998 Dec 15;71(4):467-78.

Abstract

CDK9 has been recently shown to have increased kinase activity in differentiated cells in culture and a differentiated tissue-specific expression in the developing mouse. In order to identify factors that contribute to CDK9's differentiation-specific function, we screened a mouse embryonic library in the yeast two-hybrid system and found a tumor necrosis factor signal transducer, TRAF2, to be an interacting protein. CDK9 interacts with a conserved domain in the TRAF-C region of TRAF2, a motif that is known to bind other kinases involved in TRAF-mediated signaling. Endogenous interaction between the two proteins appears to be specific to differentiated tissue. TRAF2-mediated signaling may incorporate additional kinases to signal cell survival in myotubes, a cell type that is severely affected in TRAF2 knockout mice.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Binding Sites
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Cyclin-Dependent Kinase 9
  • Humans
  • Mice
  • Muscle, Skeletal / cytology*
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism
  • NF-kappa B / metabolism
  • Protein Kinases / genetics
  • Protein Kinases / metabolism*
  • Proteins / genetics
  • Proteins / isolation & purification
  • Proteins / metabolism*
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Subcellular Fractions
  • TNF Receptor-Associated Factor 2
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • NF-kappa B
  • Proteins
  • Recombinant Proteins
  • TNF Receptor-Associated Factor 2
  • Tumor Necrosis Factor-alpha
  • Protein Kinases
  • CDK9 protein, human
  • Cdk9 protein, mouse
  • Cyclin-Dependent Kinase 9